Gimeracil

吉莫斯特

Report date: 2023/08/02 20:00:51

Base Information

Drug NameGimeracil
Drug Alias Name吉美嘧啶
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropyrimidine dehydrogenase inhibitors
TargetsDihydropyrimidine dehydrogenase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A